Mismatch repair deficiency in metastatic prostate cancer (PC): Response to PD-1 blockade and standard therapies

被引：0
|
作者：
Graham, Laura
Montgomery, Robert B.
Cheng, Heather H.
Yu, Evan Y.
Alva, Ajjai Shivaram
Schweizer, Michael Thomas
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
194
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer.
    Cercek, Andrea
    Sinopoli, Jenna Cohen
    Shia, Jinru
    Weiss, Jill A.
    Temple, Lindsay
    Smith, Jesse Joshua
    Saltz, Leonard B.
    Widmar, Maria
    Fumo, Gerard
    Aparo, Santiago
    Romesser, Paul Bernard
    Walch, Henry S.
    Patel, Mitesh
    Jayaprakasam, Vetri Sudar
    Kim, Tae-Hyung
    Paty, Philip
    Gonen, Mithat
    Garcia-Aguilar, Julio
    Weiser, Martin R.
    Diaz Jr, Luis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA3512 - LBA3512
  • [32] PD-1 blockade therapy for cancer
    Ribas, Antoni
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [33] Cancer immunotherapy by PD-1 blockade
    Honjo, Tasuku
    CANCER SCIENCE, 2018, 109 : 197 - 197
  • [34] Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma
    Albiges, Laurence
    Fay, Andre P.
    Xie, Wanling
    Krajewski, Katherine
    McDermott, David F.
    Heng, Daniel Y. C.
    Dariane, Charles
    DeVelasco, Guillermo
    Lester, Renee
    Escudier, Bernard
    Choueiri, Toni K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (17) : 2580 - 2586
  • [35] SMOKING HISTORY AND PD-1/PDL-1 PATHWAY BLOCKADE: PREDICTING RESPONSE TO TREATMENT IN METASTATIC CANCER
    Sullivan, C. M.
    Lu, J.
    Kucharczyk, J.
    Vesselinovitch, D.
    Khurana, N.
    Matrana, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 594 - 594
  • [36] Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a POLE. Mutation
    Gong, Jun
    Wang, Chongkai
    Lee, Peter P.
    Chu, Peiguo
    Fakih, Marwan
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (02): : 142 - 147
  • [37] PD-1 BLOCKADE IN CANCER IMMUNOTHERAPY
    Srivastava, N.
    Avigan, D.
    Rosenblatt, J.
    DRUGS OF THE FUTURE, 2014, 39 (02) : 129 - 132
  • [38] Efficacy of PD-1 blockade in tumors with MMR deficiency
    Lee, Valerie
    Le, Dung T.
    IMMUNOTHERAPY, 2016, 8 (01) : 1 - 3
  • [39] Immunotherapy PD-1 blockade exploiting MMR deficiency
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (08) : 459 - 459
  • [40] Mismatch repair deficiency and clinical implications in prostate cancer
    Graham, Laura S.
    Schweizer, Michael T.
    PROSTATE, 2022, 82 : S37 - S44
12345